v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance at Dec. 31, 2024 $ 12,979 $ 74,424,651 $ (48,504,388) $ 25,933,242
Beginning balance (in shares) at Dec. 31, 2024 12,978,741      
Net income (loss) (1,323,924) (1,323,924)
Issuance of common stock upon settlement of restricted stock, net $ 30 30
Issuance of common stock upon settlement of restricted stock, net (in shares) 30,553      
Stock-based compensation expense 320,199 320,199
Ending balance at Mar. 31, 2025 $ 13,009 74,744,850 (49,828,312) 24,929,547
Ending balance (in shares) at Mar. 31, 2025 13,009,294      
Beginning balance at Dec. 31, 2024 $ 12,979 74,424,651 (48,504,388) 25,933,242
Beginning balance (in shares) at Dec. 31, 2024 12,978,741      
Net income (loss)       (2,648,883)
Ending balance at Jun. 30, 2025 $ 12,978 74,913,464 (51,153,271) 23,773,171
Ending balance (in shares) at Jun. 30, 2025 12,978,259      
Beginning balance at Mar. 31, 2025 $ 13,009 74,744,850 (49,828,312) 24,929,547
Beginning balance (in shares) at Mar. 31, 2025 13,009,294      
Net income (loss) (1,324,959) (1,324,959)
Issuance of common stock upon settlement of restricted stock, net $ (31) (31)
Issuance of common stock upon settlement of restricted stock, net (in shares) (31,035)      
Stock-based compensation expense 168,614 168,614
Ending balance at Jun. 30, 2025 $ 12,978 74,913,464 (51,153,271) 23,773,171
Ending balance (in shares) at Jun. 30, 2025 12,978,259      
Beginning balance at Dec. 31, 2025 $ 13,155 75,142,168 (49,347,749) $ 25,807,574
Beginning balance (in shares) at Dec. 31, 2025 13,155,061     13,155,061
Net income (loss) 1,236,718 $ 1,236,718
Issuance of common stock upon settlement of restricted stock, net $ 34 34
Issuance of common stock upon settlement of restricted stock, net (in shares) 34,000      
Stock-based compensation expense 235,253 235,253
Ending balance at Mar. 31, 2026 $ 13,189 75,377,421 (48,111,031) 27,279,579
Ending balance (in shares) at Mar. 31, 2026 13,189,061      
Beginning balance at Dec. 31, 2025 $ 13,155 75,142,168 (49,347,749) $ 25,807,574
Beginning balance (in shares) at Dec. 31, 2025 13,155,061     13,155,061
Net income (loss)       $ 1,922,333
Ending balance at Jun. 30, 2026 $ 13,228 75,523,591 (47,425,416) $ 28,111,403
Ending balance (in shares) at Jun. 30, 2026 13,227,806     13,227,806
Beginning balance at Mar. 31, 2026 $ 13,189 75,377,421 (48,111,031) $ 27,279,579
Beginning balance (in shares) at Mar. 31, 2026 13,189,061      
Net income (loss) 685,615 685,615
Issuance of common stock upon settlement of restricted stock, net $ 39 39
Issuance of common stock upon settlement of restricted stock, net (in shares) 38,745      
Stock-based compensation expense 146,170 146,170
Ending balance at Jun. 30, 2026 $ 13,228 $ 75,523,591 $ (47,425,416) $ 28,111,403
Ending balance (in shares) at Jun. 30, 2026 13,227,806     13,227,806